Richard Wilson

Professor of GI Oncology

University of Glasgow

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Richard Wilson is a faculty member at the University of Glasgow, specializing in GI Oncology. His recent research focuses on novel therapeutic approaches for ovarian and colorectal cancers, as well as the efficacy of targeted therapies in breast cancer. Professor Wilson is actively involved in clinical trials assessing treatment outcomes and developing protocols to improve patient care in oncology.

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Melissa LaBonte

The Queen's University Belfast

UNITED KINGDOM

View details

Stephanie Craig

The Queen's University Belfast

UNITED KINGDOM

Queen's University Belfast

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Richard Wilson

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours

Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial.

Inhibition of WEE1 Is Effective in <i>TP53</i>- and <i>RAS</i>-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring.

Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer

Orthogonal MET analysis in a population-representative stage II-III colon cancer cohort: prognostic and potential therapeutic implications

Dataset for Pathology Reporting of Colorectal Cancer

ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel Adenocarcinoma

Do clinical trials change practice? A longitudinal, international assessment of colorectal cancer prescribing practices

Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial

Nothing to lose: a grounded theory study of patients’ and healthcare professionals’ perspectives of being involved in the consent process for oncology trials with non-curative intent

Collaborators (8)

Melissa LaBonte

Stephanie Craig

David J. Fisher

Joanna Wincenciak

Kienan Savage

ROBERT JONES

Timothy Stanley Maughan

Roisin Morelli

Make your next move.